Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 156

Results For "AI"

10415 News Found

Oval Fertility and Merck India partner to advance access to high-quality fertility care
Healthcare | June 10, 2026

Oval Fertility and Merck India partner to advance access to high-quality fertility care

Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care


Axplora consolidates global UDCA manufacturing at Vizag facility
News | June 10, 2026

Axplora consolidates global UDCA manufacturing at Vizag facility

Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market


GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio


Ten years on, PMSMA continues to shape safer motherhood in India
Policy | June 10, 2026

Ten years on, PMSMA continues to shape safer motherhood in India

7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines


AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027


Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities


Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe


HAB Pharma targets Rs. 3,000 crore revenue by 2030
News | June 10, 2026

HAB Pharma targets Rs. 3,000 crore revenue by 2030

Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions


Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
Policy | June 10, 2026

Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce

Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports


FibroFind appoints Lee Borthwick as CEO to drive global expansion
People | June 10, 2026

FibroFind appoints Lee Borthwick as CEO to drive global expansion

Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform